Last $6.43 USD
Change Today +0.05 / 0.78%
Volume 163.3K
SNSS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 1:07 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arthur Weiss M.D., Ph.D.

Member of Scientific Advisory Board, Five Prime Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 4 different organizations across 7 different industries.

See Board Relationships
----

Background*

Prof. Arthur Weiss, M.D, Ph.D works as the Ephraim P. Engleman Distinguished Professor of Medicine, Microbiology & Immunology at University of California, San Francisco and its Chief of the Division of Rheumatology in the Department of Medicine, where Dr. Weiss has been on the faculty since 1985 and became division chief of rheumatology in 1988. Dr. Weiss serves as a Director of Medical Scientist Training Program at University of California San Francisco. He is also ...

Read Full Background

Corporate Headquarters*

395 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-266-3500
Fax: 650-266-3501

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
The University of Chicago
MD
The University of Chicago
Bachelor's Degree
Johns Hopkins University
BA
Johns Hopkins University
Post-Doctoral Training
Swiss Institute for Experimental Cancer Research
Unknown/Other Education
University of California-San Francisco

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNSS:US $6.43 USD +0.05

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.